Australia announced today, Saturday, that it will continue its vaccination program with the “AstraZeneca” vaccine, after a blood clot raised concern about the safety of the vaccine.
Deputy Chief Medical Officer in Australia Michael Kidd said, according to what the Australian newspaper (The Edge) reported on its website, “We have not received advice at the present time from the Australian Technical Advisory Group for Vaccination, or the Therapeutic Goods Administration, to stop the introduction of the AstraZeneca vaccine in Australia.” .
“The risk of serious side effects is still very low, but safety is the priority, which is why the Australian Technical Advisory Group for Vaccination and the Therapeutic Goods Administration continue to work on this matter,” he added, indicating that further notices will be issued this week.
It is reported that a 44-year-old person entered a hospital in Melbourne, Australia days after receiving the “AstraZeneca” vaccine, and he was suffering from severe blood clots, a condition that prevents the normal flow through the bloodstream.
Australia launched a vaccination campaign for its population of 25 million last February, and most of them are expected to receive this vaccine, which was created by Oxford University in cooperation with a Swedish company, while 50 million doses of this vaccine are being produced locally.
The article Australia continues its vaccination program with the AstraZeneca vaccine against Corona, which was written in the Stock Exchange newspaper.